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Background
At our institution a biologics clinic has been established to
see specifically those children with JIA on anti-TNF treat-
ment. It was through regular contact with these patients
that it became apparent that some of these patients have
difficult thoughts and concerns about biological therapies
that are not being acknowledged fully. Little is published
about the psychological responses of young people with
JIA to success or failure of treatment and how they influ-
ence attitudes to future treatments.
Methods
An Interpretive Hermenutic Phenomenological approach
was used to allow in-depth examinations of the young
people's personal accounts of their lived experiences. Data
was obtained from 6 individuals (aged 10–14 yrs) with
JIA, receiving anti-TNF therapy during a routine clinic
appointment using audio-taped unstructured interviews
aided by spider diagrams. The interviews were carried out
with informed consent, after ethical approval was given.
The data were analysed using Colazzi's method.
Results
Overall response as either positive or negative, hinged on
perceived success of their biologic therapy and interest-
ingly on their relationships with school friends.
Conclusion
This study will assist in providing these patients with a
better package of care, by providing the clinician with a
deeper insight into how young people view their biologic
treatments. As one individual said "Enbrel is useless cus it
doesn't work for me. I don't get a say in anything. They
pretend you do, but you still have to take the things. It's
my body, but when I say I don't want it, they say I have to
have it".
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